EMILY HSIEH to Receptors, Antigen, T-Cell
This is a "connection" page, showing publications EMILY HSIEH has written about Receptors, Antigen, T-Cell.
Connection Strength
0.692
-
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood Adv. 2025 Nov 11; 9(21):5489-5500.
Score: 0.187
-
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Adv. 2025 Oct 28; 9(20):5249-5262.
Score: 0.186
-
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy. Blood Adv. 2022 09 13; 6(17):5222-5226.
Score: 0.150
-
Replacing CAR-T cell resistance with persistence by changing a single residue. J Clin Invest. 2020 06 01; 130(6):2806-2808.
Score: 0.128
-
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities. Transplant Cell Ther. 2024 01; 30(1):38-55.
Score: 0.040